This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narayanan, R.
Right arrow Articles by Weigel, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narayanan, R.
Right arrow Articles by Weigel, N. L.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2005, p. 2885-2898, Vol. 25, No. 8
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.8.2885-2898.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Human Progesterone Receptor Displays Cell Cycle-Dependent Changes in Transcriptional Activity

Ramesh Narayanan,1 Dean P. Edwards,2 and Nancy L. Weigel1*

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas,1 Department of Pathology and Program in Molecular Biology, University of Colorado Health Science Center, Aurora, Colorado2

Received 17 September 2004/ Returned for modification 29 October 2004/ Accepted 3 January 2005

The human progesterone receptor (PR) contains multiple Ser-Pro phosphorylation sites that are potential substrates for cyclin-dependent kinases, suggesting that PR activity might be regulated during the cell cycle. Using T47D breast cancer cells stably transfected with an mouse mammary tumor virus (MMTV) chloramphenicol acetyltransferase reporter (Cat0) synchronized in different phases of the cell cycle, we found that PR function and phosphorylation is remarkably cell cycle dependent, with the highest activity in S phase. Although PR expression was reduced in the G2/M phase, the activity per molecule of receptor was markedly reduced in both G1 and G2/M phases compared to the results seen with the S phase of the cell cycle. Although PR is recruited to the MMTV promoter equivalently in the G1 and S phases, recruitment of SRC-1, SRC-3, and, consequently, CBP is reduced in G1 phase despite comparable expression levels of SRC-1 and SRC-3. In G2/M phase, site-specific phosphorylation of PR at Ser162 and at Ser294, a site previously reported to be critical for transcriptional activity and receptor turnover, was abolished. Treatment with the histone deacetylase inhibitor trichostatin A elevated G1 and G2/M activity to that of the S phase, indicating that the failure to recruit sufficient levels of active histone acetyltransferase is the primary defect in PR-mediated transactivation.


* Corresponding author. Mailing address: Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Phone: (713) 798-6234. Fax: (713) 790-1275. E-mail: nweigel{at}bcm.tmc.edu.


Molecular and Cellular Biology, April 2005, p. 2885-2898, Vol. 25, No. 8
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.8.2885-2898.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Rohan, J. N. P., Weigel, N. L. (2009). 1{alpha},25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer Cells. Endocrinology 150: 2046-2054 [Abstract] [Full Text]  
  • Lin, W., Wu, J., Dong, H., Bouck, D., Zeng, F.-Y., Chen, T. (2008). Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells. J. Biol. Chem. 283: 30650-30657 [Abstract] [Full Text]  
  • Agoulnik, I. U., Bingman, W. E. III, Nakka, M., Li, W., Wang, Q., Liu, X. S., Brown, M., Weigel, N. L. (2008). Target Gene-Specific Regulation of Androgen Receptor Activity by p42/p44 Mitogen-Activated Protein Kinase. Mol. Endocrinol. 22: 2420-2432 [Abstract] [Full Text]  
  • Tan, B., Long, X., Nakshatri, H., Nephew, K. P, Bigsby, R. M (2008). Striatin-3{gamma} inhibits estrogen receptor activity by recruiting a protein phosphatase. J Mol Endocrinol 40: 199-210 [Abstract] [Full Text]  
  • Weigel, N. L., Moore, N. L. (2007). Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions. Mol. Endocrinol. 21: 2311-2319 [Abstract] [Full Text]  
  • Lee, K. Y., Jeong, J.-W., Wang, J., Ma, L., Martin, J. F., Tsai, S. Y., Lydon, J. P., DeMayo, F. J. (2007). Bmp2 Is Critical for the Murine Uterine Decidual Response. Mol. Cell. Biol. 27: 5468-5478 [Abstract] [Full Text]  
  • Agoulnik, I. U., Vaid, A., Nakka, M., Alvarado, M., Bingman, W. E. III, Erdem, H., Frolov, A., Smith, C. L., Ayala, G. E., Ittmann, M. M., Weigel, N. L. (2006). Androgens Modulate Expression of Transcription Intermediary Factor 2, an Androgen Receptor Coactivator whose Expression Level Correlates with Early Biochemical Recurrence in Prostate Cancer. Cancer Res. 66: 10594-10602 [Abstract] [Full Text]  
  • Proia, D. A., Nannenga, B. W., Donehower, L. A., Weigel, N. L. (2006). Dual Roles for the Phosphatase PPM1D in Regulating Progesterone Receptor Function. J. Biol. Chem. 281: 7089-7101 [Abstract] [Full Text]